- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2024. Philstar Global Corp. All Rights Reserved
X
+ Follow DR. GERRY TAN Tag
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 1312532 [Title] => Managing diabetes [Summary] =>The rapid growth of diabetes cases in the country shouldn't come as a surprise for a carbohydrate-loading nation.
[DatePublished] => 2014-04-14 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1489320 [AuthorName] => Maria Eleanor E. Valeros [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [1] => Array ( [ArticleID] => 378942 [Title] => Landmark diabetes trial seen to control blood sugar better [Summary] => You are what you eat! Whatever you feed yourself will likely speak highly or poorly of you. Like words that come out of your mouth which might be taken one day against you, what you had indulged in gastronomically during the holidays - oh, all of those tempting sweets and starchies and lots of other sinful goodies - could be detrimental to the activities of the endocrine system.
[DatePublished] => 2007-01-08 00:00:00 [ColumnID] => 133560 [Focus] => 0 [AuthorID] => 1489320 [AuthorName] => Maria Eleanor E. Valeros [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [2] => Array ( [ArticleID] => 375197 [Title] => Drug found to delay type 2 diabetes [Summary] => Type 2 diabetes patients can now look forward to the potential prevention of complications of said disease after an international study found out that rosiglitazone maleate has successfully reduced the risk of monotherapy failure in people who have the disease.
Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with rosiglitazone maleate reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin, and 63 percent compared to glyburide at five years.
[DatePublished] => 2006-12-15 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Cebu News [SectionUrl] => cebu-news [URL] => ) ) )
DR. GERRY TAN
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 1312532 [Title] => Managing diabetes [Summary] =>The rapid growth of diabetes cases in the country shouldn't come as a surprise for a carbohydrate-loading nation.
[DatePublished] => 2014-04-14 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1489320 [AuthorName] => Maria Eleanor E. Valeros [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [1] => Array ( [ArticleID] => 378942 [Title] => Landmark diabetes trial seen to control blood sugar better [Summary] => You are what you eat! Whatever you feed yourself will likely speak highly or poorly of you. Like words that come out of your mouth which might be taken one day against you, what you had indulged in gastronomically during the holidays - oh, all of those tempting sweets and starchies and lots of other sinful goodies - could be detrimental to the activities of the endocrine system.
[DatePublished] => 2007-01-08 00:00:00 [ColumnID] => 133560 [Focus] => 0 [AuthorID] => 1489320 [AuthorName] => Maria Eleanor E. Valeros [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [2] => Array ( [ArticleID] => 375197 [Title] => Drug found to delay type 2 diabetes [Summary] => Type 2 diabetes patients can now look forward to the potential prevention of complications of said disease after an international study found out that rosiglitazone maleate has successfully reduced the risk of monotherapy failure in people who have the disease.
Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with rosiglitazone maleate reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin, and 63 percent compared to glyburide at five years.
[DatePublished] => 2006-12-15 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Cebu News [SectionUrl] => cebu-news [URL] => ) ) )
abtest
By Maria Eleanor E. Valeros | April 14, 2014 - 12:00am
By Maria Eleanor E. Valeros | January 8, 2007 - 12:00am
December 15, 2006 - 12:00am
Recommended
Mapua captain Clint Escamis has made known to everyone that he only wants one thing – win the NCAA senior basketball championship.
11 hours ago
Adamson took care of business against Ateneo, 69-55, and dragged University of the East into a playoff for the last semifinals ticket in the UAAP Season 87 men’s basketball yesterday at the Filoil EcoOil Centre in San Juan.
11 hours ago
It took over a year before PBA vice chairman Alfrancis Chua agreed to reprise his role as Gilas team manager and with the added responsibility as Gilas project director, he’s ready to do his share in bringing the country’s national basketball program to new heights.
11 hours ago
Still alive.
15 hours ago
University of Santo Tomas and Adamson are heading into the UAAP Season 87 women’s basketball semifinals on a high after defeating their respective opponents Saturday at the FilOil EcoOil Centre in San Juan.
20 hours ago
Lotto Nov 23, 2024
EZ2/LVM - 7 25
SUERTRES - 0 8 2
6D Lotto - 2 3 1 5 7 1
6/42 - 18 2 40 42 26 14
P13,275,319.00
Grand Lotto - 4 17 26 9 41 7
P29,700,000.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66